Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Issues
2016
October 2016, Vol 7, No 9
October 2016, Vol 7, No 9
Hypofractionated Radiation May Be New Treatment Paradigm in Patients Unable to Receive Standard of Care
By
Phoebe Starr
ASTRO Annual Meeting
October 2016, Vol 7, No 9
Read Article
FDA News - October 2016
FDA Approvals, News & Updates
,
In the News
October 2016, Vol 7, No 9
Read Article
Radiation Boost Improves Local Control, Spares Salvage Mastectomy in Patients with Ductal Carcinoma in Situ
By
Phoebe Starr
ASTRO Meeting Highlights
October 2016, Vol 7, No 9
Read Article
Survival Increased with Value-Added Stereotactic Body Radiation Therapy in Patients with Lung Cancer
By
Phoebe Starr
ASTRO Meeting Highlights
October 2016, Vol 7, No 9
Read Article
Hematopoietic-Cell Transplants Require Substantial All-Cause Healthcare Resource Utilization
By
Jessica Miller
Value in Oncology
October 2016, Vol 7, No 9
Read Article
Palliative Care for Caregivers: Implementing Caregiver Support Programs
By
Chase Doyle
Palliative Care
,
Personalized Medicine
October 2016, Vol 7, No 9
Read Article
Implementing Clinical Pathways May Not Lower Costs
By
Jessica Miller
Clinical Pathways
October 2016, Vol 7, No 9
San Fransisco, CA—An economic model designed to determine the cost of instituting a clinical pathway inmetastatic colorectal cancer (mCRC) showed that the costs associated with implementing such a pathway may outweigh any potential cost-savings it may provide, at least for the near-term, according to Tanya G.K. Bentley, PhD, PHAR LLC, Beverly Hills, CA, and colleagues.
Read Article
Role of Cancer Cell Count in Assessing Therapy Efficacy in Prostate Cancer
By
Sophie Granger
Prostate Cancer
,
Solid Tumors
October 2016, Vol 7, No 9
Read Article
Older Drugs in “New Clothes” Achieve Superior Outcomes
By
Phoebe Starr
Hematologic Malignancies
,
Leukemia
,
Personalized Medicine
October 2016, Vol 7, No 9
Read Article
In the Literature - October 2016
In the Literature
October 2016, Vol 7, No 9
Read Article
Page 3 of 3
1
2
3
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Medication Assurance Programs, as Deceiving and Harmful as Alternate Funding Programs
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Addressing Challenges to Adoption of Value-Based Agreements
Phoebe Starr
3.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma